Enrofloxacin is a synthetic fluoroquinolone antibiotic, widely used in veterinary medicine to treat bacterial infections in animals by inhibiting bacterial DNA gyrase and topoisomerase IV. The availability… Read more






























Enrofloxacin is a synthetic fluoroquinolone antibiotic, widely used in veterinary medicine to treat bacterial infections in animals by inhibiting bacterial DNA gyrase and topoisomerase IV. The availability of accurate reference standards for this active pharmaceutical ingredient, including its related impurities and stable isotope labelled compounds, is essential for rigorous analytical testing and quality control. Laboratories rely on these materials for impurity profiling, which involves identifying and quantifying degradation products and structural analogs that may arise from processes such as hydrolysis, oxidation, or photolysis during pharmaceutical development. Whether performing routine quality monitoring or developing complex analytical methods, these compounds facilitate adherence to regulatory guidelines. This collection encompasses pharmacopeial and non-pharmacopeial impurities, alongside specific labelled standards, ensuring comprehensive support for method validation and stability studies in the assessment of Enrofloxacin.